Health News

FDA Approves Blood Sugar Monitor App
iPhones have made a huge impact on the way we access information. Can't remember the name of that one actor? Pull out your phone and the answer is there. Now, the FDA has approved a new iPhone tool for diabetes patients.
Kids ER Visits from Batteries Increasing
The increase in electronics, computers and cell phones in homes can cause more than screen-obsessed children who don't get out enough. It also means more batteries are lying around.
Cardiovascular Monitoring With Gilenya
The U.S. Food and Drug Administration (FDA) has completed its evaluation of a report of a patient who died after the first dose of multiple sclerosis drug Gilenya ( fingolimod ).
Born Into a Smoke-Free World
The effect of tobacco smoke on pregnant women and their developing babies is well-documented, but what if a baby were born into a community where no public smoking was allowed at all? The first study conducted in the U.S. to compare a city with a smoking ban to a city without one found that fewer pregnant women were smoking and fewer babies were being born early. Avoid cigarette smoke while pregnant. Robert Lee Page, II, a pharmacist in the Department of Clinical Pharmacy at the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences, led the study to inve...
Potential Dangers of Multiple Sclerosis Treatment
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation procedure” to treat chronic cerebrospinal venous insufficiency ( CCSVI ).
Revlimid and Risk of New Cancers
The U.S. Food and Drug Administration (FDA) is informing the public of an increased risk of second primary malignancies (new types of cancer) in patients with newly-diagnosed multiple myeloma who received Revlimid ( lenalidomide ).
Common Cold Remedy May Not be Best
Zinc is commonly sold as a remedy for the common cold, but whether its effective is controversial. A recent review of research shed some light on this debated treatment.
Pfizer Stops Phase 3 Trial Of Lyrica
Pfizer Inc. announced that it has stopped a Phase 3 clinical trial of Lyrica ( pregabalin ) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet.
Drug Approved for Gaucher Disease
The U.S. Food and Drug Administration approved Elelyso ( taliglucerase alfa ) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder.
Germs Living in Your Sandcastles
Going to the beach means digging in the sand, building sandcastles , being buried in sand… But most health departments have no way of determining how "clean" that sand is.